Submission for OMB Review; Comment Request; Investigating the Causes of Post Donation Information (PDI): Errors in the Donor Screening Process, 23265-23266 [2010-10283]
Download as PDF
Federal Register / Vol. 75, No. 84 / Monday, May 3, 2010 / Notices
request is made on behalf of an
organization or other entity, the
signature of a responsible official of the
organization or other entity.
ADDRESSES: All documents relating to
this determination are available for
inspection between the hours of 8:30
a.m. and 4:30 p.m., Monday through
Friday, at the following offices: Alabama
Department of Environmental
Management, Drinking Water Branch,
1400 Coliseum Boulevard, Montgomery,
Alabama 36130; and the U.S.
Environmental Protection Agency,
Region 4, Safe Drinking Water Branch,
61 Forsyth Street, SW., Atlanta, Georgia
30303.
FOR FURTHER INFORMATION CONTACT: Tom
Plouff, P.E., EPA Region 4, Safe
Drinking Water Branch, at the address
given above, by telephone at (404) 562–
9476, or at plouff.tom@epa.gov.
Authority: Section 1413 of the Safe
Drinking Water Act, as amended (1996), and
40 CFR part 142.
Dated: April 20, 2010.
J. Scott Gordon,
Acting Regional Administrator, Region 4.
[FR Doc. 2010–10173 Filed 4–30–10; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
erowe on DSK5CLS3C1PROD with NOTICES
Submission for OMB Review;
Comment Request; Investigating the
Causes of Post Donation Information
(PDI): Errors in the Donor Screening
Process
SUMMARY: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Heart, Lung, and Blood Institute
(NHLBI), the National Institutes of
Health (NIH) has submitted to the Office
of Management and Budget (OMB) a
request to review and approve the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on February 23, 2010, Volume
75, No. 35, pages 8080–8081 and
allowed 60 days for public comment.
The purpose of this notice is to allow an
additional 30 days for public comment.
The National Institutes of Health may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a current valid OMB control
number.
VerDate Mar<15>2010
15:35 Apr 30, 2010
Jkt 220001
Proposed Collection: Title:
Investigating the causes of post donation
information (PDI): Errors in the donor
screening process. Type of Information
Collection Request: NEW. Need and Use
of Information Collection: Blood centers
are required to use a health history
screening questionnaire to obtain
eligibility information for the protection
of the donor and recipient prior to blood
donation. However, the health history
process is known to be error-prone and
the reasons for those errors are largely
unknown and untested. Donors often
fail to report a risk that would have
resulted in deferral. This deferral risk
may be disclosed at a subsequent
donation and is classified as Post
Donation Information (PDI). While this
deferral risk may be at the next donation
event, many examples of PDI are not
disclosed nor discovered until several
intervening donation events have
occurred. The reasons why donors fail
to disclose a deferrable history at the
time of one donation but subsequently
disclose this information at a later time
are unidentified. This protocol is
designed to ascertain why PDI error
events occur. It will be the first study of
any kind to address the issue of PDI
errors in any systematic fashion. By
conducting interviews with donors
involved in PDI errors, we will gain
important qualitative knowledge about
this problem. Information gathered from
these interviews will not only elucidate
the issue of PDI but will provide insight
into donor understanding of the
screening process and their feelings
about the process and blood donation in
general.
The main objectives of the study are:
1. To explore reasons behind errors in
the donor screening process when
donors initially fail to disclose an
accurate and complete health history.
2. To explore PDI donors’ knowledge,
attitudes, behaviors and beliefs (KABB)
about the health history questionnaire
and their experience with the screening
process and the center.
3. To compare KABB in PDI donors to
deferred (but not PDI) donors and
accepted donors.
The study sample will consist of three
groups:
1. Donors with a PDI: all identified
donors of interest with an FDA
reportable donor suitability error
classified as PDI at the REDS–II centers.
2. Deferred donors: appropriately
deferred (but not PDI deferred donors) at
the REDS–II centers.
3. Accepted Donors: appropriately
accepted for donation at the REDS–II
centers.
Telephone interviews will be
conducted with consented donors to
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
23265
collect information regarding their
knowledge, attitudes, behaviors and
beliefs about the donor health history
process. Even though the interviews
with the donors will be individual, we
would like to form groups of similar PDI
and deferred donors for analysis
purposes.
The five groups of interest include
PDI occurrences or deferrals that are due
to:
• Travel (malaria, vCJD).
• Medical (history of diseases
including jaundice/hepatitis, surgery
and medications needed to treat disease
including Tegison, Proscar and
Accutane).
• Blood/Disease Exposure—(tattoo,
piercings, accidental needle stick).
• High Risk Behavior—Sexual (MSM,
sex with IV drug user or test-positive
individual).
• High Risk Behavior—Non-Sexual
(IV drug use, non-sexual exposure to
Hepatitis C or Hepatitis B).
All interviews will be digitallyrecorded and the recordings uploaded
onto computers as dss files; these files
will be transcribed and then coupled to
the interviewer notes to form an analytic
package for the data analysts. Once the
interview is conducted successfully,
each study donor will be mailed a check
of $25 as an incentive for participating
in the study.
The cognitive testing of the interview
guide will be conducted at the
Hoxworth Blood Center. For this
purpose, the blood center staff will
identify 2 PDI and 2 deferred donors
from the five broad categories of
interest. They will also contact 2
accepted donors for study consent and
interview. These donors will be
approached and consented by following
the same procedures that will be used
for the actual study.
The data from the semi-structured
interviews will be analyzed in two
ways. The close-ended responses will be
analyzed quantitatively. This will likely
take the form of 3-way cross-tabulations
of frequency distributions in responses
to key questions. The open-ended
responses will be analyzed as
qualitative data. All analytic steps and
assumptions that led up to the
conclusions, including competing
interpretations of the data, will be fully
discussed in the final report.
Frequency of Response: Once.
Affected Public: Individuals. Type of
Respondents: Adult blood donors. The
annual reporting burden is a follows:
Estimated Number of Respondents: 408;
Estimated Number of Responses per
Respondent: 1; Average Burden of
Hours per Response: 0.08 for the initial
phone call and 0.5 for responding to the
E:\FR\FM\03MYN1.SGM
03MYN1
23266
Federal Register / Vol. 75, No. 84 / Monday, May 3, 2010 / Notices
actual interview; and Estimated Total
Annual Burden Hours Requested:
83.64.The annualized cost to
respondents is estimated at: $1505.52
(based on $18 per hour). There are no
Capital Costs to report. There are no
Operating or Maintenance Costs to
report.
Table 1: Estimate of Requested Burden
Hours and Dollar Value of Burden
Hours
TABLE A.12–1 ESTIMATES OF HOUR BURDEN
Estimated number of responses
per respondent
No. of respondents
Type of respondents
Average burden
hours per response
Estimated total
annual burden
hours requested
32.6
30
15
6
Donors initially contacted ...............................................................
PDI Donors ....................................................................................
Deferred Donors ............................................................................
Accepted Donors ...........................................................................
408
*60
*30
*12
1
1
1
1
.08
0.5
0.5
0.5
Total ........................................................................................
408
............................
............................
83.64
erowe on DSK5CLS3C1PROD with NOTICES
*These respondents are a subgroup of total 408 donors who will be initially contacted to participate in the study.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Dr.
George Nemo, Project Officer, NHLBI,
Two Rockledge Center, Suite 361, 6700
Rockledge Drive, Bethesda, MD 20892,
or call non-toll-free number 301–435–
0075, or e-mail your request, including
your address to nemog@nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
VerDate Mar<15>2010
15:35 Apr 30, 2010
Jkt 220001
Dated: April 26, 2010.
George Nemo,
Project Officer, NHLBI, National Institutes of
Health.
[FR Doc. 2010–10283 Filed 4–30–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Standardizing Antibiotic Use in LongTerm Care Settings SAUL) Study.’’ In
accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
AHRQ invites the public to comment on
this proposed information collection.
DATES: Comments on this notice must be
received by July 2, 2010.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by email at doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Proposed Project
Standardizing Antibiotic Use in LongTerm Care Settings (SAUL)
Study Inappropriate antibiotic
prescribing practices by primary care
clinicians caring for residents in longterm care (LTC) communities is
becoming a major public health concern
as it is a risk factor for morbidity and
mortality among LTC residents.
Antibiotics are among the most
commonly prescribed pharmaceuticals
in LTC settings, yet reports indicate that
a high proportion of antibiotic
prescriptions are inappropriate. The
adverse consequences of inappropriate
prescribing practices are serious and
include drug reactions/interactions,
secondary complications, and the
emergence of multi-drug resistant
organisms.
In an effort to reduce antibiotic
overprescribing, Loeb and colleagues
developed minimum criteria for the
initiation of antibiotics in LTC setting
(Loeb, M., et al. 2001). The criteria have
been tested in several studies, but their
implementation and tests of validity
have been limited. In particular, though
Loeb and colleagues developed distinct
minimum criteria for several types of
infection (skin and soft-tissue,
respiratory, urinary tract, and
unexplained fever), a rigorous
evaluation has been conducted only for
urinary tract infections.
Twelve nursing homes (NH) will
participate in this project; six NHs will
be recruited to serve as treatment sites
and six to serve as control sites. Once
a nursing home community has been
selected and randomly assigned to the
treatment or control group, a facility
recruitment letter will be sent to the
facility Administrator. The letter will
include a description of the study and
inform the Administrator that the
E:\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 75, Number 84 (Monday, May 3, 2010)]
[Notices]
[Pages 23265-23266]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-10283]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; Investigating the
Causes of Post Donation Information (PDI): Errors in the Donor
Screening Process
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Heart, Lung, and Blood Institute
(NHLBI), the National Institutes of Health (NIH) has submitted to the
Office of Management and Budget (OMB) a request to review and approve
the information collection listed below. This proposed information
collection was previously published in the Federal Register on February
23, 2010, Volume 75, No. 35, pages 8080-8081 and allowed 60 days for
public comment. The purpose of this notice is to allow an additional 30
days for public comment. The National Institutes of Health may not
conduct or sponsor, and the respondent is not required to respond to,
an information collection that has been extended, revised, or
implemented on or after October 1, 1995, unless it displays a current
valid OMB control number.
Proposed Collection: Title: Investigating the causes of post
donation information (PDI): Errors in the donor screening process. Type
of Information Collection Request: NEW. Need and Use of Information
Collection: Blood centers are required to use a health history
screening questionnaire to obtain eligibility information for the
protection of the donor and recipient prior to blood donation. However,
the health history process is known to be error-prone and the reasons
for those errors are largely unknown and untested. Donors often fail to
report a risk that would have resulted in deferral. This deferral risk
may be disclosed at a subsequent donation and is classified as Post
Donation Information (PDI). While this deferral risk may be at the next
donation event, many examples of PDI are not disclosed nor discovered
until several intervening donation events have occurred. The reasons
why donors fail to disclose a deferrable history at the time of one
donation but subsequently disclose this information at a later time are
unidentified. This protocol is designed to ascertain why PDI error
events occur. It will be the first study of any kind to address the
issue of PDI errors in any systematic fashion. By conducting interviews
with donors involved in PDI errors, we will gain important qualitative
knowledge about this problem. Information gathered from these
interviews will not only elucidate the issue of PDI but will provide
insight into donor understanding of the screening process and their
feelings about the process and blood donation in general.
The main objectives of the study are:
1. To explore reasons behind errors in the donor screening process
when donors initially fail to disclose an accurate and complete health
history.
2. To explore PDI donors' knowledge, attitudes, behaviors and
beliefs (KABB) about the health history questionnaire and their
experience with the screening process and the center.
3. To compare KABB in PDI donors to deferred (but not PDI) donors
and accepted donors.
The study sample will consist of three groups:
1. Donors with a PDI: all identified donors of interest with an FDA
reportable donor suitability error classified as PDI at the REDS-II
centers.
2. Deferred donors: appropriately deferred (but not PDI deferred
donors) at the REDS-II centers.
3. Accepted Donors: appropriately accepted for donation at the
REDS-II centers.
Telephone interviews will be conducted with consented donors to
collect information regarding their knowledge, attitudes, behaviors and
beliefs about the donor health history process. Even though the
interviews with the donors will be individual, we would like to form
groups of similar PDI and deferred donors for analysis purposes.
The five groups of interest include PDI occurrences or deferrals
that are due to:
Travel (malaria, vCJD).
Medical (history of diseases including jaundice/hepatitis,
surgery and medications needed to treat disease including Tegison,
Proscar and Accutane).
Blood/Disease Exposure--(tattoo, piercings, accidental
needle stick).
High Risk Behavior--Sexual (MSM, sex with IV drug user or
test-positive individual).
High Risk Behavior--Non-Sexual (IV drug use, non-sexual
exposure to Hepatitis C or Hepatitis B).
All interviews will be digitally-recorded and the recordings
uploaded onto computers as dss files; these files will be transcribed
and then coupled to the interviewer notes to form an analytic package
for the data analysts. Once the interview is conducted successfully,
each study donor will be mailed a check of $25 as an incentive for
participating in the study.
The cognitive testing of the interview guide will be conducted at
the Hoxworth Blood Center. For this purpose, the blood center staff
will identify 2 PDI and 2 deferred donors from the five broad
categories of interest. They will also contact 2 accepted donors for
study consent and interview. These donors will be approached and
consented by following the same procedures that will be used for the
actual study.
The data from the semi-structured interviews will be analyzed in
two ways. The close-ended responses will be analyzed quantitatively.
This will likely take the form of 3-way cross-tabulations of frequency
distributions in responses to key questions. The open-ended responses
will be analyzed as qualitative data. All analytic steps and
assumptions that led up to the conclusions, including competing
interpretations of the data, will be fully discussed in the final
report.
Frequency of Response: Once. Affected Public: Individuals. Type of
Respondents: Adult blood donors. The annual reporting burden is a
follows: Estimated Number of Respondents: 408; Estimated Number of
Responses per Respondent: 1; Average Burden of Hours per Response: 0.08
for the initial phone call and 0.5 for responding to the
[[Page 23266]]
actual interview; and Estimated Total Annual Burden Hours Requested:
83.64.The annualized cost to respondents is estimated at: $1505.52
(based on $18 per hour). There are no Capital Costs to report. There
are no Operating or Maintenance Costs to report.
Table 1: Estimate of Requested Burden Hours and Dollar Value of Burden
Hours
Table A.12-1 Estimates of Hour Burden
----------------------------------------------------------------------------------------------------------------
Estimated number Average burden Estimated total
Type of respondents No. of of responses per hours per annual burden
respondents respondent response hours requested
----------------------------------------------------------------------------------------------------------------
Donors initially contacted............. 408 1 .08 32.6
PDI Donors............................. *60 1 0.5 30
Deferred Donors........................ *30 1 0.5 15
Accepted Donors........................ *12 1 0.5 6
----------------------------------------------------------------------------------------------------------------
Total.............................. 408 ................ ................ 83.64
----------------------------------------------------------------------------------------------------------------
*These respondents are a subgroup of total 408 donors who will be initially contacted to participate in the
study.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: Desk Officer for NIH. To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Dr. George Nemo, Project Officer, NHLBI, Two
Rockledge Center, Suite 361, 6700 Rockledge Drive, Bethesda, MD 20892,
or call non-toll-free number 301-435-0075, or e-mail your request,
including your address to nemog@nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
Dated: April 26, 2010.
George Nemo,
Project Officer, NHLBI, National Institutes of Health.
[FR Doc. 2010-10283 Filed 4-30-10; 8:45 am]
BILLING CODE 4140-01-P